Skip to content
监管与产业动态· FierceBiotech·· 20 hours agoScore53

Lycia aims for $228M IPO to generate data on food allergy rival to Xolair - Fierce Biotech

In brief

Lycia plans to raise $228 million in an IPO to generate data on a food allergy candidate and position it as a competitor to Xolair.

Source: 监管与产业动态

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org